
Oncology Clinic
The Pediatric Oncology Clinic team of world-renowned childhood cancer experts includes doctors, nurses and social workers, who care for patients with every type of childhood cancer. We understand that undergoing cancer treatment is emotionally difficult, and we offer not just a helping hand, but a hand to hold.
In addition to treating patients, our doctors lead world-class research aimed at advancing the understanding and treatment of cancer. Thanks to that work, patients have the opportunity to participate in large-scale clinical trials of new therapies and drugs. Our goal is to help kids get better as quickly as possible so they can put cancer behind them and get on with their lives.
Our locations (3)
Our team
-
Katherine Matthay
MD
Pediatric hematologist-oncologist -
Anurag K. Agrawal
MD
Pediatric hematologist-oncologist -
Anuradha Banerjee
MD, MPH
Pediatric neuro-oncologist -
Barbara Beach
-
Benjamin Braun
MD
Pediatric hematologist and oncologist -
James Feusner
MD
Pediatric hematologist-oncologist -
Robert E. Goldsby
MD
Pediatric hematologist and oncologist -
Carla Golden
MD
Pediatric hematologist-oncologist -
W. Clay Gustafson
MD
Pediatric oncologist -
Robert Ward Hagar
MD
Internist -
Caroline Hastings
MD
Hematologist-oncologist and neuro-oncologist -
Michelle L. Hermiston
MD, PhD
Pediatric hematologist and oncologist -
Shannon Kelly
MD
Pediatric hematologist-oncologist -
Ashutosh Lal
MD
Pediatric hematologist-oncologist -
Mignon Loh
MD
Pediatric hematologist-oncologist -
Alice Matsunaga
MD
Pediatric hematologist and oncologist -
Jennifer Michlitsch
MD
Pediatric hematologist-oncologist -
Sabine Mueller
MD, PhD
Pediatric neurologist and neuro-oncologist -
Lynne Neumayr
MD
Pediatric hematologist and oncologist -
Robert Raphael
MD
Pediatric hematologist-oncologist -
Elizabeth Robbins
MD
Pediatric hematologist-oncologist -
Amit J. Sabnis
MD, MS
Pediatric blood disorders and cancer specialist -
Kristin Shimano
MD
Pediatric hematologist and oncologist -
Sylvia Singer
MD
Pediatric hematologist-oncologist -
Alejandro Sweet-Cordero
MD
Pediatric oncologist -
Elliott Vichinsky
MD
Pediatric hematologist-oncologist -
Mark Walters
MD
Pediatric hematologist-oncologist
Awards & recognition
-
Best in Northern California for cancer care
-
Ranked among the nation's best in 10 specialties
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your child's condition
- List of medications, including dosages, plus any your child is allergic to
- List of questions you may have
- Device or paper for taking notes
- Completed medical forms that we will mail to you ahead of time
New visitor rules
Patients may have only one visitor at a time and switch visitors twice a day. Thanks!

Your Stay
We offer valuable information to help you plan for your child's upcoming hospital stay. Find out about food services, family accommodations and more.
Learn more
Your Child's Care Team
Our doctors, nurses, child life specialists and other providers have special training to care for children. Meet your child's care team.
Learn more
Interpreter Services & Communication Assistance
Interpreter services in many languages and TDDs are available for families that need help communicating with care teams. Here's how to access them.
Learn moreRelated clinics
(4)

Blood & Marrow Transplant (BMT) Clinic
Support services
Clinical trials
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philad...
Will compare the DFS of standard risk Philadelphia chromosome (Ph+) acute lymphoblastic leukemia (ALL) patients treated continuous imatinib mesylate with high risk Children's Oncology Group (COG)-ALL chemotherapy backbone or more ...
Recruiting
More about this studyPonatinib With Chemotherapy in Pediatric Participants With Relapsed, Resistant, or Intolerant P...
The RP2D is the maximum tolerated dose (MTD) or less.
Recruiting
More about this studySelpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders W...
Will be determined by Response Evaluation Criteria in Solid Tumors. Response rates will be calculated as the percent of evaluable patients who are responders, and confidence intervals will be constructed using the Wilson score int...
Recruiting
More about this studyTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Re...
Response rates will be calculated as the percent of evaluable patients who are responders, and confidence intervals will be constructed using the Wilson score interval method.
Recruiting
More about this studyTipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With ...
A responder is defined as a patient who achieves a best response of partial response or complete response on the study. Response rates will be calculated as the percent of evaluable patients who are responders, and confidence inte...
Recruiting
More about this studyBGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Glioma...
Events occurring on or after treatment on Day 1 will be summarized by mapped term, appropriate thesaurus level, and CTCAE v5.0 grade. Adverse events leading to treatment discontinuation will be listed.
Recruiting
More about this studyA Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Dia...
Will be assessed in SR-High patients and SR-Avg B-ALL patients who are negative for MRD by flow cytometry but have detectable or indeterminate MRD as measured by high throughput sequencing (HTS) at end of induction (EOI), and pati...
Recruiting
More about this studyOur research initiatives
Feeling at home
From bedside bingo to therapy dogs, we're here to help kids smile and feel more like themselves.
